Exagen Inc. (NASDAQ: XGN)
$5.0000
-0.0200 ( -1.96% ) 65.8K
Exagen Inc is a commercial-stage diagnostics company committed to addressing the unmet need for the accurate diagnosis and monitoring of patients affected by autoimmune rheumatic diseases. It currently markets ten testing products under its Avise brand to provide an accurate, timely, and differential diagnosis and to optimize the treatment of ARDs. It markets and sells solutions to community rheumatologists.
Market Data
Open
$5.0000
Previous close
$5.0200
Volume
65.8K
Market cap
$88.54M
Day range
$4.7480 - $5.2200
52 week range
$1.3003 - $6.2200
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
8-k/a | 8K-related | 13 | Aug 02, 2024 |
4 | Insider transactions | 1 | Jun 14, 2024 |
3 | Insider transactions | 2 | Jun 14, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
4 | Insider transactions | 1 | Jun 12, 2024 |
8-k | 8K-related | 13 | Jun 11, 2024 |
4 | Insider transactions | 1 | May 16, 2024 |
10-q | Quarterly Reports | 61 | May 13, 2024 |